Category: Life Sciences
Global Life Sciences
-
Commercial Greenhouse
... CAGR of 8.9% over the analysis period 2024-2030. Heating Systems, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$20.3 Billion by the end of the analysis ... Read More
-
Counter Cyber Terrorism
... at a CAGR of 2.8% over the analysis period 2024-2030. Firewall, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$19.1 Billion by the end of the ... Read More
-
Cryostat
... 4.6% over the analysis period 2024-2030. Continuous-Flow Cryostat, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth ... Read More
-
Dermatology Diagnostic Devices
... at a CAGR of 9.2% over the analysis period 2024-2030. Lasers, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$19.2 Billion by the end of the ... Read More
-
Digestive Enzyme Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Animal Source, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$817.7 Million by the end of ... Read More
-
Downstream Processing
... CAGR of 15.6% over the analysis period 2024-2030. Purification Technique, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$60.6 Billion by the end of the analysis ... Read More
-
Drug Abuse Testing
... at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Services, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$52.0 Billion by the end of ... Read More
-
Electroceramics
... 5.4% over the analysis period 2024-2030. Dielectric Ceramics, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$7.7 Billion by the end of the analysis period. Growth ... Read More
-
Emergency Department Information Systems
... 2030, growing at a CAGR of 11.9% over the analysis period 2024-2030. Enterprise Solutions, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$1.1 Billion by the ... Read More
-
Emergency Contraceptive Pills
... at a CAGR of 2.4% over the analysis period 2024-2030. Combination Pills, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$484.2 Million by the end of ... Read More
-
Fall Detection Systems
... at a CAGR of 4.8% over the analysis period 2024-2030. Automatic Fall Detection Systems, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$431.8 Million by the ... Read More
-
Flow Chemistry
... CAGR of 8.8% over the analysis period 2024-2030. CSTR, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More
-
Foley Catheters
... CAGR of 5.1% over the analysis period 2024-2030. 2-Way Foley Catheters, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Gas Generators
... CAGR of 5.8% over the analysis period 2024-2030. Industrial End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.9 Billion by the end of the analysis ... Read More
-
Gastrointestinal Stents
... CAGR of 5.9% over the analysis period 2024-2030. Biliary Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$382.2 Million by the end of the analysis ... Read More
-
Guidewires
... 4.2% over the analysis period 2024-2030. Stainless Steel Guidewires, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$303.5 Million by the end of the analysis period. ... Read More
-
Healthcare Cold Chain Logistics
... 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$11.1 Billion by the end ... Read More
-
Cardiac Surgery Instruments
... at a CAGR of 5.4% over the analysis period 2024-2030. Forceps, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$957.4 Million by the end of the ... Read More
-
Container Monitoring
... CAGR of 34.4% over the analysis period 2024-2030. Container Monitoring Services, one of the segments analyzed in the report, is expected to record a 36.5% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Critical Care Equipment
... at a CAGR of 5.7% over the analysis period 2024-2030. Patient Monitors, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Critical Care Therapeutics
... at a CAGR of 5.7% over the analysis period 2024-2030. Albumin, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
Curcumin
... 8.7% over the analysis period 2024-2030. Conventional Curcumin, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$139.3 Million by the end of the analysis period. Growth ... Read More
-
De-Aromatic Solvents
... CAGR of 4.2% over the analysis period 2024-2030. Medium Flash Point Solvents, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$956.7 Million by the end of ... Read More
-
Dermatology Devices
... CAGR of 9.5% over the analysis period 2024-2030. Treatment Devices, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$20.5 Billion by the end of the analysis ... Read More
Research Assistance
